86 related articles for article (PubMed ID: 16627249)
21. High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia.
Harada H; Harada Y; Niimi H; Kyo T; Kimura A; Inaba T
Blood; 2004 Mar; 103(6):2316-24. PubMed ID: 14615365
[TBL] [Abstract][Full Text] [Related]
22. Mutations of the AML1 gene in acute myeloid leukemia of FAB types M0 and M7.
Langabeer SE; Gale RE; Rollinson SJ; Morgan GJ; Linch DC
Genes Chromosomes Cancer; 2002 May; 34(1):24-32. PubMed ID: 11921279
[TBL] [Abstract][Full Text] [Related]
23. Transcriptional dysregulation during myeloid transformation in AML.
Pabst T; Mueller BU
Oncogene; 2007 Oct; 26(47):6829-37. PubMed ID: 17934489
[TBL] [Abstract][Full Text] [Related]
24. Low frequency of exon 3 PTPN11 mutations in adult de novo acute myeloid leukemia. Analysis of a consecutive series of 173 patients.
Nomdedéu J; Carricondo MT; Lasa A; Perea G; Aventin A; Sierra J
Haematologica; 2005 Mar; 90(3):412-3. PubMed ID: 15749679
[TBL] [Abstract][Full Text] [Related]
25. Importance of early detection and follow-up of FLT3 mutations in patients with acute myeloid leukemia.
Colovic N; Tosic N; Aveic S; Djuric M; Milic N; Bumbasirevic V; Colovic M; Pavlovic S
Ann Hematol; 2007 Oct; 86(10):741-7. PubMed ID: 17579862
[TBL] [Abstract][Full Text] [Related]
26. [Analysis of NPM1 gene mutations in acute myeloid leukemia].
Yan LZ; Chen SN; Liang JY; Feng YF; Cen JN; He J; Chang WR; Zhu ZL; Pan JL; Wu YF; Xue YQ; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2007 May; 28(5):289-93. PubMed ID: 17877154
[TBL] [Abstract][Full Text] [Related]
27. Mutations in the p53 gene in acute myeloid leukemia patients correlate with poor prognosis.
Melo MB; Ahmad NN; Lima CS; Pagnano KB; Bordin S; Lorand-Metze I; SaAd ST; Costa FF
Hematology; 2002 Feb; 7(1):13-9. PubMed ID: 12171773
[TBL] [Abstract][Full Text] [Related]
28. Point mutations in the AML1/RUNX1 gene associated with myelodysplastic syndrome.
Harada H; Harada Y
Crit Rev Eukaryot Gene Expr; 2005; 15(3):183-96. PubMed ID: 16390315
[TBL] [Abstract][Full Text] [Related]
29. Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study.
Paschka P; Marcucci G; Ruppert AS; Mrózek K; Chen H; Kittles RA; Vukosavljevic T; Perrotti D; Vardiman JW; Carroll AJ; Kolitz JE; Larson RA; Bloomfield CD;
J Clin Oncol; 2006 Aug; 24(24):3904-11. PubMed ID: 16921041
[TBL] [Abstract][Full Text] [Related]
30. Haploinsufficiency of Runx1/AML1 promotes myeloid features and leukaemogenesis in BXH2 mice.
Yamashita N; Osato M; Huang L; Yanagida M; Kogan SC; Iwasaki M; Nakamura T; Shigesada K; Asou N; Ito Y
Br J Haematol; 2005 Nov; 131(4):495-507. PubMed ID: 16281942
[TBL] [Abstract][Full Text] [Related]
31. Somatic CEBPA mutations are a frequent second event in families with germline CEBPA mutations and familial acute myeloid leukemia.
Pabst T; Eyholzer M; Haefliger S; Schardt J; Mueller BU
J Clin Oncol; 2008 Nov; 26(31):5088-93. PubMed ID: 18768433
[TBL] [Abstract][Full Text] [Related]
32. Mutations of the HIPK2 gene in acute myeloid leukemia and myelodysplastic syndrome impair AML1- and p53-mediated transcription.
Li XL; Arai Y; Harada H; Shima Y; Yoshida H; Rokudai S; Aikawa Y; Kimura A; Kitabayashi I
Oncogene; 2007 Nov; 26(51):7231-9. PubMed ID: 17533375
[TBL] [Abstract][Full Text] [Related]
33. Trisomy 13 correlates with RUNX1 mutation and increased FLT3 expression in AML-M0 patients.
Silva FP; Lind A; Brouwer-Mandema G; Valk PJ; Giphart-Gassler M
Haematologica; 2007 Aug; 92(8):1123-6. PubMed ID: 17650443
[TBL] [Abstract][Full Text] [Related]
34. [Distinct genetic pathway in the molecular pathogenesis of MDS/AML with AML1/RUNX1 point mutations].
Harada H
Rinsho Ketsueki; 2007 Jul; 48(7):541-6. PubMed ID: 17695302
[No Abstract] [Full Text] [Related]
35. Microsatellite instability and p53 mutations are characteristic of subgroups of acute myeloid leukemia but independent events.
Herzog G; Lu-Hesselmann J; Zimmermann Y; Haferlach T; Hiddemann W; Dreyling M
Haematologica; 2005 May; 90(5):693-5. PubMed ID: 15921389
[TBL] [Abstract][Full Text] [Related]
36. Amplification of AML1 gene in association with karyotype, age and diagnosis in acute leukemia patients.
Kirschnerová G; Tóthová A; Babusíková O
Neoplasma; 2006; 53(2):150-4. PubMed ID: 16575471
[TBL] [Abstract][Full Text] [Related]
37. May the correlation between Kit-D816 mutation and AML1-ETO level change the use of prognostic factors in t(8;21) AML?
Potenza L; Luppi M; Riva G; Ottaviani E; Zucchini P; Morselli M; Volzone F; Forghieri F; Martinelli G; Torelli G
Leuk Res; 2007 Feb; 31(2):269-71. PubMed ID: 16759701
[No Abstract] [Full Text] [Related]
38. [Flt-3/ITD mutation in pediatric leukemia and its clinical significance].
Wang J; Wang T; Li S; Lin L; Gang Y
Ai Zheng; 2007 Jan; 26(1):58-63. PubMed ID: 17222369
[TBL] [Abstract][Full Text] [Related]
39. Spectrum and significance of variants and mutations in the Fanconi anaemia group G gene in children with sporadic acute myeloid leukaemia.
Meyer S; Barber LM; White DJ; Will AM; Birch JM; Kohler JA; Ersfeld K; Blom E; Joenje H; Eden TO; Malcolm Taylor G
Br J Haematol; 2006 May; 133(3):284-92. PubMed ID: 16643430
[TBL] [Abstract][Full Text] [Related]
40. Identification of the novel AML1 fusion partner gene, LAF4, a fusion partner of MLL, in childhood T-cell acute lymphoblastic leukemia with t(2;21)(q11;q22) by bubble PCR method for cDNA.
Chinen Y; Taki T; Nishida K; Shimizu D; Okuda T; Yoshida N; Kobayashi C; Koike K; Tsuchida M; Hayashi Y; Taniwaki M
Oncogene; 2008 Apr; 27(15):2249-56. PubMed ID: 17968322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]